Light Chain Bioscience (Novimmune)

Light Chain Bioscience (Novimmune)

Verified
Develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders

Financials

Edit
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
$14mSeries A
$46mSeries B
N/AN/AEarly VC
Not yet verified
$54.8mSeries C
N/A$22.4mSeries D
N/AN/AEarly VC
Not yet verified
N/A€6mGrant
$66mSeries E
*
€27mSeries F
Total Funding$240m

Recent News about Light Chain Bioscience (Novimmune)

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.